Lexicon Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXRX and other ETFs, options, and stocks.About LXRX
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes.
LXRX Key Statistics
Stock Snapshot
With a market cap of 619.6M, Lexicon Pharmaceuticals(LXRX) trades at $1.70. The stock has a price-to-earnings ratio of -8.97.
On 2026-01-24, Lexicon Pharmaceuticals(LXRX) stock traded between a low of $1.65 and a high of $1.83. Shares are currently priced at $1.70, which is +3.0% above the low and -7.1% below the high.
Lexicon Pharmaceuticals(LXRX) shares are trading with a volume of 3.46M, against a daily average of 3.43M.
In the last year, Lexicon Pharmaceuticals(LXRX) shares hit a 52-week high of $1.83 and a 52-week low of $0.28.
In the last year, Lexicon Pharmaceuticals(LXRX) shares hit a 52-week high of $1.83 and a 52-week low of $0.28.
LXRX News
Lexicon Pharmaceuticals, Inc. ( ) shares have had a really impressive month, gaining 28% after a shaky period beforehand. The last 30 days bring the annual gain...
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals, with a price target of $4.00. Claim 50% Of...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.